A novel approach to treating anxiety and enhancing executive skills in an older adult with parkinsong's disease

Clinical Case Studies

Volumn 9, Issue 1, 2010, Pages 74-90

  Mohlman, Jan ^a   Reel, Dorian Hunter ^a   Chazin, Daniel ^a   Ong, Diana ^a   Georgescu, Bianca ^a   Tiu, Jade ^a   Dobkin, Roseanne D ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Aging; Anxiety; Cognitive behavior therapy; Cognitive enhancement; Executive skills; Parkinsong's disease

Indexed keywords

AGED; ANAMNESIS; ANXIETY DISORDER; BRADYKINESIA; CASE REPORT; COGNITION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; GROUP THERAPY; HUMAN; MALE; MUSCLE TONE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PSYCHODYNAMICS; QUALITY OF LIFE; REVIEW; SEXUAL ABUSE; TREATMENT DURATION;

EID: 77952564753     PISSN: 15346501     EISSN: 15523802     Source Type: Journal    
DOI: 10.1177/1534650109351305     Document Type: Review

References (78)

1. Alexopoulos, G.S., Kiosses, D.N., Klimstra, S., & Kalayam, B. (2002). Clinical presentation of the "depression-executive dysfunction syndrome" of late life. American Journal of Geriatric Psychiatry, 10, 98-106. (Pubitemid 34052908)
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders - text revision (4 th ed.). Washington, DC: Author.
3. Army Individual Test Battery. (1944). Manual of directions and scoring. Washington, DC: War Department, Adjutant Generalg's Office.
4. Barlow, D.H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2 nd ed.). New York: Guilford.
5. Basso, M.R., Bornstein, R.A., & Lang, J.M. (1999). Practice effects on commonly used measures of executive function across twelve months. Clinical Neuropsychologist, 13, 283-292.
6. Beck, A.T., & Steer, R.A. (1987). Beck Depression Inventory: Manual. San Antonio, TX: Psychiatric Corporation.
7. Beck, A.T., & Steer, R.A. (1990). Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation.
8. Benton, A.L., & Hamsher, K. (1976). Multilingual aphasia examination (2 nd ed.). Iowa City, IA: AJA Associates.
9. Burns, D.D. (2000). Feeling good: The new mood therapy. New York: Quill.
10. Coelho, C.A. (2005). Direct attention training as a treatment for reading impairment in mild aphasia. Apahasiology, 19, 275-283.
11. Cools, R. (2006). Dopaminergic modulation of cognitive function-Implications for L-dopa treatment in Parkinsong's disease. Neuroscience & Biobehavioral Reviews, 30, 1-23. (Pubitemid 41779404)
12. Dennis, N.A., & Cabeza, R. (2008). Neuroimaging of healthy cognitive aging. In F. I. M. Craik and T. A. Salthouse (Eds.) The handbook of aging and cognition (3 rd ed., pp. 1-54). New York, NY: Psychology Press.
13. Dobkin, R., Allen, L., & Menza, M. (2006). A cognitive behavioral package for depression in Parkinsong's Disease. Psychosomatics, 47, 259-263. (Pubitemid 46940486)
14. Dreisig, H., Beckmann, J., Wermuth, L., Skovlund, S., & Bech, P. (1999). Psychologic effects of structured cognitive psychotherapy in young patients with Parkinson disease: A pilot study. Nordic Journal of Psychiatry, 53, 217-221. (Pubitemid 29505032)
15. Ehrt, U., & Aarsland, D. (2005). Psychiatric aspects of Parkinsong's disease. Current Opinions in Psychiatry, 18, 335-341.
16. Feeney, F., Egan. S., & Gasson, N. (2005). Treatment of depression and anxiety in Parkinsong's disease: A pilot study using group cognitive behavioural therapy. Clinical Psychologist, 9, 31-38.
17. Fenelon, G., Mahieux, F., Huon, R., & Ziegler, M. (2000). Hallucinations in Parkinsong's disease: Prevalence, phenomenology and risk factors. Brain, 123, 733-745. (Pubitemid 30162723)
18. First, M.B., Gibbon, M., Spitzer, R.L., & Williams, J.B.W. (1995). Structured clinical interview for DSM-IV Axis I disorders. (version 2.0, October 1995, Final Version). New York: Biometrics Department, New York State Psychiatric Institute.
19. Folstein, S.E., Folstein, M.F., & McHugh, P.R. (1975). " Mini-mental state": A practical method for grading the mental state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
20. Forsaa, E.B., Larsen, J.P., Wentzel-Larsen, T., Herlofson, K., & Alves, G. (2008). Predictors and course of health-related quality of life in Parkinsong's disease. Movement Disorders, 23, 1420-1427.
21. Frazier, L.D., Cotrell, V., & Hooker, K. (2003). Possible selves and illness: A comparison of individuals with Parkinsong's disease, early-stage Alzheimerg's disease, and healthy older adults. International Journal of Behavioral Development, 27, 1-11. (Pubitemid 36163720)
22. Fuster, J.M. (1997). The prefrontal cortex (3 rd ed.). Philadelphia, PA: Lippincott-Raven. Goldman-Rakic, P.S., Muly, E.C. III, & Williams, G.V. (2000). D1 receptor in prefrontal cells and circuits. Brain Research, 31, 295-301.
23. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
24. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23, 56-62.
25. Hariri, A.R., Bookheimer, S.Y., & Mazziotta, J.C. (2000). Modulating emotional responses: Effects of a neocortical network on the limbic system. NeuroReport, 11, 43-48.
26. Higginson, C.I., Fields, J.A., Koller, W.C., & Troster, A.I. (2001). Questionnaire assessment potentially overestimates anxiety in Parkinsong's Disease. Journal of Clinical Psychology in Medical Settings, 8, 95-99.
27. Himadi, W.G., Boyce, R., & Barlow, D.H. (1986). Assessment of agoraphobia II: Measurement of clinical change. Behaviour Research & Therapy, 24, 321-332.
28. Hoehn, M., & Yahr, M. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427-442.
29. Kaplan, E.F., Goodglass, H., & Weintraub, H. (1983). The Boston naming test (2 nd ed.). Philadelphia, PA: Lea & Febiger.
30. Kinsella, K., & Velkoff, V.A. (2001). An aging world: 2001. Washington, DC: U.S. Government Printing Office.
31. Kulisevsky, J., Pagonabarraga, J., Pascual-Sedano, B., Garcia-Sanchez, C., Gironell A., & Trapecio Group Study. (2008). Prevalence and correlates of neuropsychiatric symptoms in Parkinsong's disease without dementia. Movement Disorders, 23, 1889-1896.
32. Lauterbach, E.C., Freeman, A., & Vogel, R.L. (2003). Correlates of generalized anxiety and panic attacks in dystonia and Parkinsong's disease. Cognitive & Behavioral Neurology, 16, 225-233. (Pubitemid 37517828)
33. Leroi, I., Collins, D., & Marsh, L. (2006). Non-dopaminergic treatment of cognitive impairment and dementia in Parkinsong's disease: A review. Journal of Neurological Sciences, 248, 104-114. (Pubitemid 44647299)
34. Levy, M.L., & Cummings, J.L. (2000). Parkinsong's disease. In E. Lauterbach (Ed.), Psychiatric management in neurologic disease (pp. 41-70). Arlington, VA: American Psychiatric Publishing.
35. Lezak, M.D., Howieson, D.B., Loring, D.W., Hannay, H.J., & Fischer, J.S. (2004). Neuropsychological assessment (4 th ed.). New York: Oxford University Press.
36. Lieberman, M.A. (2007). Psychological characteristics of people with Parkinsong's disease who prematurely drop out of professionally led Internet chat support groups. Cyber Psychology & Behavior, 10, 741-748.
37. Mark, M.H. (2006). Pathogenesis, diagnosis, and treatment. In M. Menza & L. Marsh (Eds.), Psychiatric issues in Parkinsong's disease: A practical guide (pp. 1-17). London: Taylor & Francis.
38. Marsh, L. (2000). Anxiety disorders in Parkinsong's disease. International Review of Psychiatry, 12, 307-318.
39. Marsh, L., Vaughan, C., Schretlen, D., Brandt, J., & Mandir A.S. (2000). Psychomotor aspects of mood disorders in Parkinsong's disease. Biological Psychiatry, 47, 165S - 165S.
40. McCaffrey, R.J., & Westerveldt, H.J. (1995). Issues associated with repeated neuropsychological assessments. Neuropsychology Review, 5, 203-221.
41. McDougall, G.J. (2009). A framework for cognitive interventions targeting everyday memory performance and memory self-efficacy. Family and Community Health, 32, 515-526.
42. McNamara, P., Durso, R., & Harris, E. (2006). Frontal lobe mediation of the sense of self: Evidence from studies of patients with Parkinsong's disease. In A. P. Prescott (Ed.), The concept of self in medicine health care (pp. 143-161). Hauppauge, NY: Nova Science Publishers.
43. McQuinlan, A.D., Licht, M.H., & Licht, B.G. (2003). Contributions of disease severity and perceptions of primary and secondary control to the prediction of psychosocial adjustment to Parkinsong's disease. Health Psychology, 22, 504-512.
44. Menza, M., & Dobkin, R.D. (2005). Anxiety and Parkinsong's disease. Primary Psychiatry, 12, 30-34.
45. Menza, M., & Dobkin, R.D. (2006). Anxiety. In M. Menza & L. Marsh (Eds.), Psychiatric issues in Parkinsong's disease: A practical guide (pp. 139-153). New York: Taylor & Francis.
46. Meyer, T.J., Miller, M.L., Metzger, R.L., & Borkovec, T.D. (1990). Development and validity of the Penn State Worry Scale. Behaviour Research & Therapy, 28, 487-495.
47. Mitte, K., Noack, P., Stell, R., & Hautzinger, M. (2005). A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. Journal of Clinical Psychopharmacology, 25, 141-150. (Pubitemid 40395092)
48. Mohlman, J. (2004). Psychosocial treatment of late life generalized anxiety disorder: Current status and future directions. Clinical Psychology Review, 24, 149-169. (Pubitemid 38470001)
49. Mohlman, J. (2008). More power to the executive? CBT plus executive training for late life generalized anxiety disorder. Cognitive & Behavioral Practice, 15, 306-316.
50. Mohlman, J., Gorenstein, E.E., Kleber, M.S., de Jesus, M., Gorman, J.M., & Papp, L.A. (2003). Standard and enhanced cognitive behavior therapy for late life generalized anxiety disorder: Two pilot investigations. American Journal of Geriatric Psychiatry, 11, 24-32. (Pubitemid 36091340)
51. Mohlman, J., & Gorman, J.M. (2005). The role of executive functioning in CBT: A pilot study with anxious older adults. Behaviour Research & Therapy, 43, 447-465. (Pubitemid 40208588)
52. Palmese, C.A., & Raskin, S.A. (2000). The rehabilitation of attention in individuals with mild traumatic brain injury using the APT-II programme. Brain Injury, 14, 535-548.
53. Pascual-Sedano, B., Kulisevsky, J., Barbanoj, M., Garcia-Sanchez, C., Campolongo, A., Gironell, A., et al. (2008). Levodopa and executive performance in Parkinsong's disease: A randomized study. Journal of the International Neuropsychological Society, 14, 832-841.
54. Pero, S., Incoccia, C., Caracciolo, B., Zoccolotti, P., & Formisano, R. (2006). Rehabilitation of attention in two patients with traumatic brain injury by means of "attention process training." Brain Injury, 20, 1207-1219. (Pubitemid 44811435)
55. Rektorova, I., Rektor, I., Bares, M., Dostal, V., Ehler, E., Fiedler, J., et al. (2003). Pramipexole and pergolide in the treatment of depression in Parkinsong's disease. International Journal of Geriatric Psychiatry, 10, 399-406.
56. Richard, I.H., Frank, S., McDermott, M.P., Wang, H., Justus, A.W., LaDonna, K.A., et al. (2004). The ups and downs of Parkinsong's disease: A prospective study of mood and anxiety fluctuations. Cognitive & Behavioral Neurology, 17, 201-207. (Pubitemid 40066237)
57. Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Forstl, H., Henn, F., et al. (2008). Cognitive impairment in 873 patients with idiopathic Parkinsong's disease. Journal of Neurology, 255, 255-264.
58. Ryder, K.A., Gontkovsky, S.T., McSwan, K.L., Scott, J.G., Bharucha, K.J., & Beatty, W.W. (2002). Cognitive function in Parkinsong's disease: Association with anxiety but not depression. Aging, Neuropsychology, & Cognition, 9, 77-84.
59. Schrag, A., & Jahanshahi, N.Q. (2004). What contributes to quality of life in patients with Parkinsong's disease? Journal of Neurology, Neurosurgery, & Psychiatry, 69, 308-331.
60. Shear, M.K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M.W., et al. (2001). Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale. Depression & Anxiety, 13, 166-178. (Pubitemid 32550226)
61. Shulman, L.M., Taback, R.L., Bean, J., & Weiner, W.J. (2001). Comorbidity of the non-motor symptoms of Parkinsong's disease. Movement Disorders, 16, 507-510.
62. Silverstein, S.M., Hatashita-Wong, M., Solar, B.A., Uhlhaas, P., Landa, Y., Wilkness, S.M., et al. (2005). Effectiveness of a two-phase cognitive rehabilitation intervention for severely impaired schizophrenia patients. Psychological Medicine, 35, 829-837. (Pubitemid 40873383)
63. Sinforiani, E., Banchieri, L., Zucchella, C., Pacchetti, C., & Sandrini, G. (2004). Cognitive rehabilitation in Parkinsong's disease. Archives of Gerontology & Geriatrics, Suppl 9, 387-391.
64. Sohlberg, M.M., Johnson, L., Paule, L., Raskin, S.A., & Mateer, C.A. (2001). Attention process training-II. Wake Forest, NC: Lash & Associates.
65. Sohlberg, M.M., McLaughlin, K.A., Pavese, A., Heidrich, A., & Posner, M.I. (2000). Evaluation of attention process training and brain injury education in persons with acquired brain injury. Journal of Clinical & Experimental Neuropsychology, 22, 656-676.
66. Spear Bassett, S. (2006). Cognitive impairment. In M. Menza & L. Marsh (Eds.), Psychiatric issues in Parkinsong's disease: A practical guide (pp. 63-75). London: Taylor & Francis.
67. Spielberger, C.D., Gorsuch, R.L., Lushene, P.R., Vagg, P.R., & Jacobs, A.G. (1983). Manual for the State-Trait Anxiety Inventory Test (Form Y). Palo Alto, CA: Consulting Psychological Press.
68. Stanley, M.A., Beck, J.G., & Glassco, J.D. (1996). Treatment of generalized anxiety in older adults: A preliminary comparison of cognitive-behavioral and supportive approaches. Behavior Therapy, 27, 565-581.
69. Stanley, M.A., Beck, J.G., Novy, D.M., Averill, P.M., Swann, A.C., Diefenbach, G.J., et al. (2003). Cognitive-behavioral treatment of late-life generalized anxiety disorder. Journal of Consulting & Clinical Psychology, 71, 309-319. (Pubitemid 36323935)
70. Tariot, P.N. (2001). Maintaining cognitive function in Alzheimerg's disease. Alzheimer Disease and Associated Disorders, 15, S26 - S33.
71. Trenerry, M.R., Crosson, B., DeBoe, J., & Leber, W.R. (1989). Stroop neuropsychological screening test manual. Odessa, FL: Psychological Assessment Resources.
72. Thommessen, B., Aarsland, D., Braekhus, A., Oksengaard, A.R., Engedal, K., & Laake, K. (2002). The psychosocial burden on spouses of the elderly with stroke, dementia, and Parkinsong's disease. International Journal of Geriatric Psychiatry, 17, 78-84. (Pubitemid 34121101)
73. Troster, A.I., Woods, S.P., & Morgan, E.E. (2007). Assessing cognitive change in Parkinsong's disease: Development of practice effect = corrected reliable change indices. Archives of Clinical Neuropsychology, 22, 711-718.
74. Walsh, K., & Bennett, G. (2001). Parkinsong's disease and anxiety. Postgraduate Medicine Journal, 77, 89-93.
75. Wechsler, D. (1997). Wechsler adult intelligence scale and Wechsler memory scale technical manual (3 rd ed.). San Antonio, TX: Psychological Corporation.
76. Weintraub, D., & Stern, M.B. (2005). Psychiatric complications in Parkinson disease. American Journal of Geriatric Psychiatry, 13, 844-851. (Pubitemid 46638672)
77. Wetherell, J.L., Gatz, M., & Craske, M.G. (2003). Treatment of generalized anxiety disorder in older adults. Journal of Consulting & Clinical Psychology, 71, 31-40. (Pubitemid 36150947)
78. Williams, J.B.W. (1988). A structured interview guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry, 45, 742-747.